Short interest in Cullinan Therapeutics Inc (NASDAQ:CGEM) increased during the last reporting period, rising from 8.71M to 9.16M. This put 18.23% of the company's publicly available shares short.

Short interest for Cullinan Therapeutics gives investors a sense of the degree to which investors are betting on the decline of Cullinan Therapeutics's stock. Short interest data is updated every two weeks.

Based on the recent average volume of 541.20K shares traded per day, it would take 16.92 day(s) for holders of this short interest to close out their positions without sending the stock sharply higher.